Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hisanori Horiuchi is active.

Publication


Featured researches published by Hisanori Horiuchi.


Cell | 1997

A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function

Hisanori Horiuchi; Roger Lippé; Heidi M. McBride; Mariantonietta Rubino; Philip G. Woodman; Harald Stenmark; Vladimir Rybin; Matthias Wilm; Keith Ashman; Matthias Mann; Marino Zerial

The small GTPase Rab5 plays an essential role in endocytic traffic. Rab GDP dissociation inhibitor delivers Rab5 to the membrane, where a nucleotide exchange activity allows recruitment of an effector protein, Rabaptin-5. Here we uncovered a novel 60 kDa Rab5-binding protein, Rabex-5. Rabex-5 forms a tight physical complex with Rabaptin-5, and this complex is essential for endocytic membrane fusion. Sequencing of mammalian Rabex-5 by nanoelectrospray mass spectrometry and cloning revealed striking homology to Vps9p, a yeast protein implicated in endocytic traffic. Rabex-5 displays GDP/GTP exchange activity on Rab5 upon delivery of the GTPase to the membrane. This demonstrates that a soluble exchange factor coupled to a Rab effector translocates from cytosol to the membrane, where the complex stabilizes the GTPase in the active state.


Journal of the American College of Cardiology | 1991

Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients.

Masakiyo Nobuyoshi; Takeshi Kimura; Hiroto Ohishi; Hisanori Horiuchi; Hideyuki Nosaka; Naoya Hamasaki; Hiroatsu Yokoi; Koutaku Kim

Histopathologic examination was performed in 20 patients undergoing antemortem coronary angioplasty. Thirty-four lesions were dilated and the interval between coronary angioplasty and death ranged from several hours to 4 years. Intimal proliferation of smooth muscle cells, as a major cause of restenosis, was observed in 83% to 100% of 28 lesions examined 11 days to 2 years after coronary angioplasty. In 20 lesions examined within 6 months, proliferating smooth muscle cells were predominantly of the synthetic type and there was abundant extracellular matrix substance chiefly composed of proteoglycans. In eight lesions examined between 6 months and 2 years, contractile type smooth muscle cells were dominant and extracellular matrix was composed chiefly of collagen. In three lesions examined after 2 years, evidence of antemortem coronary angioplasty was hardly identifiable and these lesions were almost indistinguishable from conventional atherosclerotic plaque. These temporal changes in histologic pattern provide a pathologic background for clinical reports that restenosis is predominantly found within 6 months after coronary angioplasty. Morphometric analysis revealed that the extent of intimal proliferation was significantly greater in lesions with evidence of medial or adventitial tears than in lesions with no or only intimal tears.


International Journal of Hematology | 2007

Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan

Shouichi Ohga; Shinsaku Imashuku; Masaki Yasukawa; Hiroyuki Tsuda; Ikuo Miura; Ken Yamamoto; Hisanori Horiuchi; Kenzo Takada; Koichi Ohshima; Shigeo Nakamura; Naoko Kinukawa; Kazuo Oshimi; Keisei Kawa

Hemophagocytic lymphohistiocytosis (HLH), a disorder of the mononuclear phagocyte system, can be classified into two distinct forms: primary HLH (FHL) and secondary HLH. To clarify the epidemiology and clinical outcome for each HLH subtype, we conducted a nationwide survey of HLH in Japan. Since 799 patients were diagnosed in 292 institutions of Japan between 2001 and 2005, the annual incidence of HLH was estimated as 1 in 800,000 per year. Among them, 567 cases were actually analyzed in this study. The most frequent subtype was Epstein-Barr virus (EBV)-associated HLH, followed by other infection- or lymphoma-associated HLH. Age distribution showed a peak of autoimmune disease- and infection-associated HLH in children, while FHL and lymphoma-associated HLH occurred almost exclusively in infants and the elderly, respectively. The 5-year overall survival rate exceeded 80% for patients with EBV- or other infection-associated HLH, was intermediate for those with FHL or B-cell lymphoma-associated HLH, and poor for those with T/NK cell lymphoma-associated HLH (<15%). Although this nationwide survey establishes the heterogeneous characteristics of HLH, the results should be useful in planning prospective studies to identify the most effective therapy for each HLH subtype.


Annals of the New York Academy of Sciences | 2006

Role of Oxidized LDL in Atherosclerosis

Toru Kita; Noriaki Kume; Manabu Minami; Kazutaka Hayashida; Toshinori Murayama; Hideto Sano; Hideaki Moriwaki; Hiroshi Kataoka; Eiichiro Nishi; Hisanori Horiuchi; Hidenori Arai; Masayuki Yokode

Abstract: A critical event in the early stages of atherosclerosis is the focal accumulation of lipid‐laden foam cells derived from macrophages. In various cholesterol‐fed animal models of atherosclerosis, localized attachment of circulating monocytes to arterial endothelial cells appeared to precede the formation of foam cells. It is suggested that monocyte recruitment into early lesions depends on the endothelial adhesiveness for monocytes and lymphocytes. In vivo and in vitro experiments have identified molecules, such as ICAM‐1, VCAM‐1, and P‐selectin, that can support the adhesion of monocytes and lymphocytes. Moreover, oxidized LDL, lysophosphatidyl‐choline, and oxidized fatty acids induce the expression not only of these adhesion molecules but also of scavenger receptors, such as CD‐36, SR‐A, and LOX‐1. Recently, we isolated and characterized the novel receptors for oxidized LDL, namely, LOX‐1 and SR‐PSOX. Expression of LOX‐1 is found on endothelial cells, smooth muscle cells, and macrophages, whereas SR‐PSOX is expressed on macrophages. In this paper the significance of oxidized LDL and its receptors, LOX‐1 and SR‐PSOX, in terms of atherogenesis is discussed.


The EMBO Journal | 1994

RAB ESCORT PROTEIN-1 IS A MULTIFUNCTIONAL PROTEIN THAT ACCOMPANIES NEWLY PRENYLATED RAB PROTEINS TO THEIR TARGET MEMBRANES

Kirill Alexandrov; Hisanori Horiuchi; O Steele-Mortimer; Miguel C. Seabra; Marino Zerial

Rab proteins comprise a family of small GTPases that serve a regulatory role in vesicular membrane traffic. Geranylgeranylation of these proteins on C‐terminal cysteine motifs is crucial for their membrane association and function. This post‐translational modification is catalysed by rab geranylgeranyl transferase (Rab‐GGTase), a multisubunit enzyme consisting of a catalytic heterodimer and an accessory component, named rab escort protein (REP)‐1. Previous in vitro studies have suggested that REP‐1 presents newly synthesized rab proteins to the catalytic component of the enzyme, and forms a stable complex with the prenylated proteins following the transfer reaction. According to this model, a cellular factor would be required to dissociate the rab protein from REP‐1 and to allow it to recycle in the prenylation reaction. RabGDP dissociation inhibitor (RabGDI) was considered an ideal candidate for this role, given its established function in mediating membrane association of prenylated rab proteins. Here we demonstrate that dissociation from REP‐1 and binding of rab proteins to the membrane do not require RabGDI or other cytosolic factors. The mechanism of REP‐1‐mediated membrane association of rab5 appears to be very similar to that mediated by RabGDI. Furthermore, REP‐1 and RabGDI share several other functional properties, the ability to inhibit the release of GDP and to remove rab proteins from membranes; however, RabGDI cannot assist in the prenylation reaction. These data suggest that REP‐1 is per se sufficient to chaperone newly prenylated rab proteins to their target membranes.


Oncogene | 2002

Involvement of nectin in the localization of junctional adhesion molecule at tight junctions

Atsunori Fukuhara; Kenji Irie; Hiroyuki Nakanishi; Kyoji Takekuni; Tomomi Kawakatsu; Wataru Ikeda; Akio Yamada; Tatsuo Katata; Tomoyuki Honda; Tatsuhiro Sato; Kazuya Shimizu; Harunobu Ozaki; Hisanori Horiuchi; Toru Kita; Yoshimi Takai

Junctional adhesion molecule (JAM) is a Ca2+-independent immunoglobulin-like cell–cell adhesion molecule which localizes at tight junctions (TJs). Claudin is a key cell–cell adhesion molecule that forms TJ strands at TJs. JAM is associated with claudin through their cytoplasmic tail-binding protein, ZO-1. JAM is furthermore associated with Par-3, a cell polarity protein which forms a ternary complex with Par-6 and atypical protein kinase C. Nectin is another Ca2+-independent immunoglobulin-like cell–cell adhesion molecule which localizes at adherens junctions (AJs). Nectin is associated with E-cadherin through their respective cytoplasmic tail-binding proteins, afadin and catenins, and involved in the formation of AJs cooperatively with E-cadherin. We show here that nectin is furthermore involved in the localization of JAM at TJs. During the formation of the junctional complex consisting of AJs and TJs in Madin-Darby canine kidney (MDCK) cells, JAM was recruited to the nectin-based cell–cell adhesion sites. This recruitment of JAM was inhibited by nectin inhibitors, which inhibited the trans-interaction of nectin. Microbeads coated with the extracellular fragment of nectin, that interacted with cellular nectin, also recruited JAM to the bead–MDCK cell contact sites. Furthermore, when cadherin-deficient L fibroblasts stably expressing both exogenous JAM and nectin (nectin-JAM-L cells) were co-cultured with L fibroblasts expressing only nectin (nectin-L cells), JAM was concentrated at the cell–cell adhesion sites between nectin-JAM-L and nectin-L cells without the trans-interaction of JAM. Analyses of the localization and immunoprecipitation of JAM revealed that it was associated with nectin through afadin and ZO-1. These results suggest that nectin has a role in the localization of JAM at TJs in the process of the formation of the junctional complex in epithelial cells.


Journal of Biological Chemistry | 2000

Small GTPase Rab4 Regulates Ca2+-induced α-Granule Secretion in Platelets

Ryutaro Shirakawa; Akira Yoshioka; Hisanori Horiuchi; Hiroaki Nishioka; Arata Tabuchi; Toru Kita

Upon activation, platelets release many active substances stored in α- and dense-core granules. However, the molecular mechanisms governing regulated exocytosis are not yet fully understood. Here, we have established an assay system using permeabilized platelets to analyze the Ca2+-induced exocytosis of both types of granules, focusing on RabGTPases. Incubation with Rab GDP dissociation inhibitor, an inhibitory regulator of RabGTPases, reduced membrane-bound RabGTPases extensively, and caused strong inhibition of the Ca2+-induced secretion of von Willebrand factor (vWF) stored in α-granules, but not that of [3H]5-hydroxytryptamine (5-HT) in dense-core granules. Specifically, Rab4 co-fractionated with vWF and P-selectin (an α-granule marker) upon separation of platelet organelles by density gradient centrifugation. Incubation of the permeabilized platelets with cell extracts expressing the dominant negative mutant of His-tagged Rab4S22N, but not with those of similar mutant His-Rab3BT36N, inhibited the vWF secretion, whereas neither of the cell extracts affected the [3H]5-HT secretion. Importantly, the inhibition of vWF secretion was rescued by depleting the cell extracts of the His-Rab4S22N with nickel beads. Thus, in platelets, the regulatory mechanisms governing α- and dense-core granule secretions are distinct, and Rab4 is an essential regulator of the Ca2+-induced exocytosis of α-granules.


The EMBO Journal | 1997

Cleavage of Rabaptin-5 blocks endosome fusion during apoptosis

Sabina Cosulich; Hisanori Horiuchi; Marino Zerial; Paul R. Clarke; Philip G. Woodman

Cells undergoing apoptosis exhibit striking changes in membrane organization, including plasma membrane blebbing and invagination, vacuolation and fragmentation of organelles, and alterations in the surface expression of receptors. The underlying mechanisms for these changes are unknown, though alterations in vesicular fusion are likely to play a role. Using a cell‐free system based on Xenopus laevis egg extracts we have found that endosome fusion is blocked during apoptosis. Inhibition of fusion is prevented by Bcl‐2 or Bcl‐xL, two negative regulators of apoptosis, or by specific inhibitors of members of the caspase family of apoptotic proteases. Selective cleavage of Rabaptin‐5, an essential and rate‐limiting component of endosome fusion, is responsible for the loss of fusion activity. Cleavage of Rabaptin‐5 also occurs in cellular models for apoptosis. These results suggest that inactivation of Rabaptin‐5 and inhibition of vesicle transport lead to fragmentation of endosomes and inhibition of the endocytic pathway during the execution phase of apoptosis. We propose that parallel changes to other membrane transport pathways would give rise to general membrane fragmentation in apoptotic cells. These changes are likely to play an important role in the generation of apoptotic bodies and their recognition by phagocytosing cells.


Journal of Cell Biology | 2012

Munc13-4 reconstitutes calcium-dependent SNARE-mediated membrane fusion

Kristin L. Boswell; Declan J. James; Joseph Esquibel; Stephen Bruinsma; Ryutaro Shirakawa; Hisanori Horiuchi; Thomas F. J. Martin

Munc13-4 is a Ca2+-dependent membrane- and SNARE-binding protein that promotes membrane fusion.


European Journal of Heart Failure | 2010

Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin.

Shin Watanabe; Toshihiro Tamura; Koh Ono; Hisanori Horiuchi; Takeshi Kimura; Toru Kita; Yutaka Furukawa

Insulin‐like growth factor (IGF)‐I is a regulator of glucose/fatty acid metabolism and may be involved in the pathophysiology of cardiovascular disease, but it remains unclear whether endogenous IGF‐I is associated with the prognosis of heart failure (HF). We investigated whether the IGF axis, the ratio of IGF‐I to IGF‐binding protein‐3 (IGFBP‐3), was a predictor of clinical outcomes in HF. The association of IGF axis with serum adiponectin level, a prognostic marker of HF as well as a regulator of glucose/fatty acid metabolism, was also analysed.

Collaboration


Dive into the Hisanori Horiuchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masakiyo Nobuyoshi

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Hideyuki Nosaka

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge